AF
OREX

Advisornet Financial’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Advisornet Financial’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,590
Closed – – 1710
2018
Q2 		$0 Hold
1,590
– – ﹤0.01% 1713
2018
Q1 		$0 Hold
1,590
– – ﹤0.01% 1514
2017
Q4 		$2K Buy
+1,590
New +$2.59K ﹤0.01% 1206

Advisornet Financial's OREX Position: Q3 2018 in Review

Advisornet Financial sold out of Orexigen Therapeutics, Inc. (OREX) in Q3 2018, closing a stake of 1,590 shares.

Advisornet Financial first reported a position in OREX in Q4 2017 and held it in 3 quarters. The position peaked at $2K in Q4 2017. 1 fund tracked by Wall St. Rank holds OREX as of Q3 2018.

  • Advisornet Financial reported no remaining Orexigen Therapeutics, Inc. position as of Q3 2018 after selling out during the quarter.
  • Advisornet Financial sold 1,590 Orexigen Therapeutics, Inc. shares in Q3 2018.
  • Advisornet Financial first reported a position in Orexigen Therapeutics, Inc. in Q4 2017 and held it in 3 quarters.
  • Advisornet Financial's Orexigen Therapeutics, Inc. position peaked at $2K in Q4 2017.
  • 1 fund tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q3 2018.

Based on Advisornet Financial's 13F filing for Q3 2018, filed 14 Nov 2018.